Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lubner David Charles
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-11-23
Purchase
2022-11-28
4:03 pm
POINT Biopharma Global Inc.PNTLubner David Charles
Director
3,600$6.85$24,6603,600
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-07-05
Option Award
2022-07-06
6:21 pm
N/A
2030-07-30
Dyne Therapeutics Inc.DYNLubner David Charles
Director
7,222$07,222
(Direct)
View
2022-06-14
Option Award
2022-06-16
5:05 pm
N/A
2032-06-13
Vor Biopharma Inc.VORLubner David Charles
Director
16,911$016,911
(Direct)
View
2022-06-03
Option Award
2022-06-06
4:07 pm
N/A
2032-06-02
Dyne Therapeutics Inc.DYNLubner David Charles
Director
19,596$019,596
(Direct)
View
2022-06-02
Option Award
2022-06-06
4:04 pm
N/A
2028-06-02
POINT Biopharma Global Inc.PNTLubner David Charles
Director
25,614$025,614
(Direct)
View
2021-03-12(A)
Option Award
2022-03-09
6:15 pm
N/A
2031-03-11
Gemini Therapeutics Inc.GMTXLubner David Charles
Director
17,529$017,529
(Direct)
View
2021-10-04(A)
Option Award
2022-03-09
6:13 pm
N/A
N/A
Gemini Therapeutics Inc.GMTXLubner David Charles
Director
0$00
(Direct)
View
2022-02-08
Conversion
2022-02-09
5:52 pm
N/A
N/A
Arcellx Inc.ACLXLubner David Charles
Director
21,659$021,659
(Direct)
View
2022-02-03
Option Award
2022-02-07
6:00 pm
N/A
2032-02-03
Arcellx Inc.ACLXLubner David Charles
Director
61,538$061,538
(Direct)
View
2022-02-03
Ownership
2022-02-03
5:29 pm
N/A
2030-08-31
Arcellx Inc.ACLXLubner David Charles
Director
0$0132,484
(Direct)
View
2021-10-04
Option Award
2021-10-06
4:15 pm
N/A
2031-10-03
Gemini Therapeutics Inc.GMTXLubner David Charles
Director
17,245$017,245
(Direct)
View
2021-07-06
Option Award
2021-07-08
4:38 pm
N/A
2027-07-06
POINT Biopharma Global Inc.PNTLubner David Charles
Director
25,000$025,000
(Direct)
View
2021-05-26
Option Award
2021-05-27
8:37 pm
N/A
2031-05-25
Dyne Therapeutics Inc.DYNLubner David Charles
Director
19,596$019,596
(Direct)
View
2021-03-12
Option Award
2021-04-07
4:07 pm
N/A
2031-02-04
Gemini Therapeutics Inc.GMTXLubner David Charles
Director
58,855$058,855
(Direct)
View
2021-03-12
Option Award
2021-03-15
4:18 pm
N/A
2031-03-11
Gemini Therapeutics Inc.GMTXLubner David Charles
Director
25,000$025,000
(Direct)
View
2021-02-05
Ownership
2021-02-10
5:32 pm
N/A
2030-10-15
Gemini Therapeutics Inc.GMTXLubner David Charles
Director
0$050,338
(Direct)
View
2021-02-05
Option Award
2021-02-09
5:13 pm
N/A
2031-02-04
Vor Biopharma Inc.VORLubner David Charles
Director
16,900$016,900
(Direct)
View
2021-02-04
Ownership
2021-02-04
9:47 pm
N/A
2030-08-24
Vor Biopharma Inc.VORLubner David Charles
Director
0$041,196
(Direct)
View
2020-07-31
Conversion
2020-09-23
7:10 pm
N/A
N/A
Dyne Therapeutics Inc.DYNLubner David Charles
Director
231,497$0257,097
(Direct)
View
2020-07-31
Option Award
2020-09-23
7:10 pm
N/A
2030-07-30
Dyne Therapeutics Inc.DYNLubner David Charles
Director
25,600$0257,097
(Direct)
View
2020-09-16
Ownership
2020-09-16
8:53 pm
N/A
2030-03-18
Dyne Therapeutics Inc.DYNLubner David Charles
Director
0$0112,033
(Direct)
View
2020-07-07
Ownership
2020-07-07
9:51 pm
N/A
N/A
Therapeutics Acquisition Corp.TXACLubner David Charles
Director
0$030,000
(Direct)
View
2020-04-02
Disposition
2020-04-03
09:02 am
N/A
2026-03-01
Ra Pharmaceuticals Inc.RARXLubner David Charles
Executive VP and CFO
554,842$00
(Direct)
View
2020-04-02
Disposition
2020-04-03
09:02 am
N/A
N/A
Ra Pharmaceuticals Inc.RARXLubner David Charles
Executive VP and CFO
15,622$480
(Direct)
View
2019-06-07
Disposition
2019-06-07
4:36 pm
N/A
2028-02-27
Nightstar Therapeutics plcNITELubner David Charles
Director
18,200$13.230
(Direct)
View
2019-06-07
Disposition
2019-06-07
4:36 pm
N/A
N/A
Nightstar Therapeutics plcNITELubner David Charles
Director
29,124$25.50
(Direct)
View
2019-06-07
Disposition
2019-06-07
4:36 pm
N/A
2029-01-24
Nightstar Therapeutics plcNITELubner David Charles
Director
21,000$11.930
(Direct)
View
2019-02-01
Exercise
2019-02-05
7:39 pm
N/A
N/A
Ra Pharmaceuticals Inc.RARXLubner David Charles
Executive V.P. & CFO
10,417$0160,959
(Direct)
View
2019-02-01
Tax Withholding
2019-02-05
7:39 pm
N/A
N/A
Ra Pharmaceuticals Inc.RARXLubner David Charles
Executive V.P. & CFO
3,291$21160,959
(Direct)
View
2019-02-01
Option Award
2019-02-05
7:39 pm
N/A
2029-02-01
Ra Pharmaceuticals Inc.RARXLubner David Charles
Executive V.P. & CFO
133,000$0160,959
(Direct)
View
2019-01-25
Option Award
2019-01-29
9:03 pm
N/A
2029-01-24
Nightstar Therapeutics plcNITELubner David Charles
Director
21,000$021,000
(Direct)
View
2019-01-01
Ownership
2019-01-02
9:07 pm
N/A
N/A
Nightstar Therapeutics plcNITELubner David Charles
Director
0$047,324
(Direct)
View
(A) Indicate amendment filing.